Does Medicaid Cover Wegovy in Ohio? Approved Conditions and Appeals

Ohio Medicaid does not cover Wegovy when it is prescribed for weight loss. Starting in early 2026, the program began covering Wegovy for two specific non-obesity uses: reducing cardiovascular risk in certain adults with heart disease, and treating a form of fatty liver disease called MASH. Both require prior authorization and strict clinical criteria. Anyone asking whether Medicaid covers Wegovy in Ohio for weight management alone will get a no.¹²

The Two Conditions Ohio Medicaid Will Approve Wegovy For

In January 2026, Ohio Medicaid’s Pharmacy and Therapeutics Committee created a drug class called “Metabolic Modifiers: GLP-1 Receptor Agonists for Non-Obesity Indications.” Wegovy sits on it as a preferred drug with clinical prior authorization.²

Cardiovascular Risk Reduction

To qualify under this pathway, you must be 18 or older, have a BMI of at least 27, and have documented atherosclerotic cardiovascular disease, which can include a prior heart attack, prior stroke, or symptomatic peripheral artery disease. You also have to already be taking standard cardiovascular medications. Patients with type 1 or type 2 diabetes are excluded from this pathway.²

MASH (Metabolic Dysfunction-Associated Steatohepatitis)

The second approved use is MASH, a serious form of fatty liver disease. You must be 18 or older, non-diabetic, and have confirmed moderate to advanced liver fibrosis, documented either by a liver biopsy within the past 24 months or by a combination of diagnostic tests. You must also be following a reduced-calorie diet and a physical activity program.²

How Long Approval Lasts

Authorizations under either pathway last 180 days. To get a renewal, you need to show at least five percent weight loss from baseline and at least 80 percent medication adherence based on pharmacy claims.²

Why Weight-Loss Use Is Excluded

The exclusion lives in Ohio Administrative Code Rule 5160-9-03, which lists “drugs for the treatment of obesity” among categories the Medicaid pharmacy program will not pay for. The same rule goes further than a simple non-coverage call: these drugs are explicitly ineligible for prior authorization, so a prescriber cannot request a one-off exception through the normal clinical approval route.¹

The policy applies the same way across every Ohio Medicaid plan. Since January 2020, the state has used a Unified Preferred Drug List covering fee-for-service Medicaid and every managed care plan, and the member handbook for the state’s single pharmacy benefit administrator lists drugs for the treatment of obesity as an excluded service.³⁴ Switching plans will not change the answer.

Federal law allows this. States running Medicaid drug programs generally have to cover nearly all FDA-approved drugs, but a long-standing statutory carve-out lets them exclude drugs used for weight loss. As of January 2026, only 13 state Medicaid programs covered GLP-1s for obesity, and the count had been shrinking as states like California, Pennsylvania, New Hampshire, and South Carolina dropped coverage.⁵

GLP-1 Coverage for Type 2 Diabetes Is Different

If you have type 2 diabetes, GLP-1 coverage opens up, but not for Wegovy. Ohio Medicaid covers Ozempic on its preferred formulary with prior authorization. Mounjaro (tirzepatide) is also available, but the state requires you to try Ozempic first or document why you cannot. To qualify for Mounjaro, you need a hemoglobin A1C above seven percent and an inadequate response after at least 120 days on Ozempic.⁶ The reason for the split is legal: states must cover GLP-1s for diabetes and, since 2024, for cardiovascular disease and obstructive sleep apnea, while weight-loss coverage stays optional.⁵

Non-Drug Obesity Treatments Ohio Medicaid Does Cover

The exclusion is on anti-obesity drugs, not on obesity care generally. A 2024 analysis by the GWU STOP Obesity Alliance found that Ohio Medicaid covers nutrition counseling and provides intensive behavioral therapy with some limitations, though the services are not obesity-specific. Metabolic and bariatric surgery is covered with restrictions.⁷

What Could Change This

Nothing on the horizon has yet moved the exclusion, but a few efforts are worth tracking.

At the Statehouse, Representatives Josh Williams and Dontavius Jarrells introduced House Bill 388, which would set up a reimbursement program for state employees using GLP-1s, not a Medicaid change. It would require the Department of Administrative Services to reimburse up to $500 per month in the first year of treatment and $250 per month in the second year, capped at 24 months, for employees with a BMI of 30 or higher. As of mid-2026, the bill was still in the House General Government Committee.⁸

The Medicaid rule itself, 5160-9-03, is not scheduled for its next routine five-year review until February 2029.¹

Federally, a proposed CMS rule that would have required state Medicaid programs to cover anti-obesity medications was not finalized. The final rule released in April 2025 omitted the mandate; CMS said it “reserves the right to include provisions in future rulemaking.”⁹ CMS also launched a voluntary five-year program called BALANCE in December 2025, under which the agency negotiates lower GLP-1 prices with manufacturers; state Medicaid agencies can apply to participate starting in May 2026. The available information does not indicate whether Ohio has signaled any intent to join.¹⁰

Appealing a Wegovy Denial

Because the weight-loss exclusion is a blanket policy and not a clinical judgment on your individual case, an appeal of a Wegovy denial for weight management alone is very unlikely to succeed. An appeal makes more sense if you believe you meet the cardiovascular or MASH criteria and were denied anyway.

If you are in a managed care plan, file an internal appeal with the plan within 60 days of the denial notice. The plan has 15 days to resolve a standard appeal and 72 hours for an expedited one when the situation is urgent. To keep receiving current benefits during the appeal, file within 15 days of the denial.¹¹

If the plan upholds the denial, request a state hearing from the Ohio Department of Job and Family Services Bureau of State Hearings within 120 days of the plan’s resolution. Hearings can be requested by mail, fax, email, online, or phone, and decisions are typically issued within 70 days.¹¹ For help, Ohio Legal Help can be reached at 866-529-6446 and Disability Rights Ohio at 800-282-9181.¹²

1
Ohio Legislative Service Commission. Rule 5160-9-03 Coverage of Drugs
2
Ohio Department of Medicaid. Pharmacy and Therapeutics Committee Meeting Minutes, January 7, 2026
3
Ohio Department of Medicaid. Unified Preferred Drug List
4
Ohio Department of Medicaid. SPBM Member Handbook
5
KFF. Medicaid Coverage of and Spending on GLP-1s
6
Ohio Department of Medicaid. Unified Preferred Drug List Changes, Effective January 1, 2026
7
GWU STOP Obesity Alliance. Ohio State Snapshot, Medicaid Obesity Coverage 2024
8
Ohio General Assembly. House Bill 388
9
CMS. Contract Year 2026 Policy and Technical Changes Final Rule Fact Sheet
10
CMS. BALANCE Model
11
Disability Rights Ohio. Medicaid Appeals Overview
12
Ohio Medicaid Health. Appeals